A 51-year-old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment

Am J Hematol. 2009 Oct;84(10):679-82. doi: 10.1002/ajh.21489.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Aphasia / etiology*
  • Ataxia / etiology*
  • Benzamides
  • Blast Crisis / diagnosis*
  • Blast Crisis / etiology
  • Blast Crisis / pathology
  • Blast Crisis / therapy
  • Confusion / etiology*
  • Cytarabine / administration & dosage
  • Cytarabine / therapeutic use
  • Diagnosis, Differential
  • Hearing Loss / etiology*
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Male
  • Middle Aged
  • Piperazines / administration & dosage
  • Piperazines / adverse effects
  • Piperazines / therapeutic use*
  • Pyrimidines / administration & dosage
  • Pyrimidines / adverse effects
  • Pyrimidines / therapeutic use*
  • Stem Cell Transplantation
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Cytarabine
  • Imatinib Mesylate